These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 22124880)
1. Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects. Rebello S; Zhao S; Hariry S; Dahlke M; Alexander N; Vapurcuyan A; Hanna I; Jarugula V Eur J Clin Pharmacol; 2012 May; 68(5):697-708. PubMed ID: 22124880 [TBL] [Abstract][Full Text] [Related]
2. Grapefruit juice greatly reduces the plasma concentrations of the OATP2B1 and CYP3A4 substrate aliskiren. Tapaninen T; Neuvonen PJ; Niemi M Clin Pharmacol Ther; 2010 Sep; 88(3):339-42. PubMed ID: 20664534 [TBL] [Abstract][Full Text] [Related]
3. Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Bailey DG; Dresser GK; Leake BF; Kim RB Clin Pharmacol Ther; 2007 Apr; 81(4):495-502. PubMed ID: 17301733 [TBL] [Abstract][Full Text] [Related]
4. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Dresser GK; Bailey DG; Leake BF; Schwarz UI; Dawson PA; Freeman DJ; Kim RB Clin Pharmacol Ther; 2002 Jan; 71(1):11-20. PubMed ID: 11823753 [TBL] [Abstract][Full Text] [Related]
5. Intestinal drug transporter expression and the impact of grapefruit juice in humans. Glaeser H; Bailey DG; Dresser GK; Gregor JC; Schwarz UI; McGrath JS; Jolicoeur E; Lee W; Leake BF; Tirona RG; Kim RB Clin Pharmacol Ther; 2007 Mar; 81(3):362-70. PubMed ID: 17215845 [TBL] [Abstract][Full Text] [Related]
6. Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides. Dresser GK; Kim RB; Bailey DG Clin Pharmacol Ther; 2005 Mar; 77(3):170-7. PubMed ID: 15735611 [TBL] [Abstract][Full Text] [Related]
7. A modified grapefruit juice eliminates two compound classes as major mediators of the grapefruit juice-fexofenadine interaction: an in vitro-in vivo "connect". Won CS; Lan T; Vandermolen KM; Dawson PA; Oberlies NH; Widmer WW; Scarlett YV; Paine MF J Clin Pharmacol; 2013 Sep; 53(9):982-90. PubMed ID: 23878024 [TBL] [Abstract][Full Text] [Related]
8. Aliskiren toxicity in juvenile rats is determined by ontogenic regulation of intestinal P-glycoprotein expression. Hoffmann P; Beckman D; McLean LA; Yan JH Toxicol Appl Pharmacol; 2014 Feb; 275(1):36-43. PubMed ID: 24388840 [TBL] [Abstract][Full Text] [Related]
9. Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren. Tapaninen T; Neuvonen PJ; Niemi M Br J Clin Pharmacol; 2011 May; 71(5):718-26. PubMed ID: 21204914 [TBL] [Abstract][Full Text] [Related]
10. Fruit juice inhibition of uptake transport: a new type of food-drug interaction. Bailey DG Br J Clin Pharmacol; 2010 Nov; 70(5):645-55. PubMed ID: 21039758 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of the oral direct renin inhibitor aliskiren in combination with digoxin, atorvastatin, and ketoconazole in healthy subjects: the role of P-glycoprotein in the disposition of aliskiren. Vaidyanathan S; Camenisch G; Schuetz H; Reynolds C; Yeh CM; Bizot MN; Dieterich HA; Howard D; Dole WP J Clin Pharmacol; 2008 Nov; 48(11):1323-38. PubMed ID: 18784280 [TBL] [Abstract][Full Text] [Related]
12. Long-lasting inhibitory effect of apple and orange juices, but not grapefruit juice, on OATP2B1-mediated drug absorption. Shirasaka Y; Shichiri M; Murata Y; Mori T; Nakanishi T; Tamai I Drug Metab Dispos; 2013 Mar; 41(3):615-21. PubMed ID: 23264447 [TBL] [Abstract][Full Text] [Related]
13. The change of pharmacokinetics of fexofenadine enantiomers through the single and simultaneous grapefruit juice ingestion. Akamine Y; Miura M; Komori H; Tamai I; Ieiri I; Yasui-Furukori N; Uno T Drug Metab Pharmacokinet; 2015 Oct; 30(5):352-7. PubMed ID: 26213156 [TBL] [Abstract][Full Text] [Related]
14. Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions. Shirasaka Y; Shichiri M; Mori T; Nakanishi T; Tamai I J Pharm Sci; 2013 Sep; 102(9):3418-26. PubMed ID: 23794501 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, safety, and tolerability of the oral Renin inhibitor aliskiren in patients with hepatic impairment. Vaidyanathan S; Warren V; Yeh C; Bizot MN; Dieterich HA; Dole WP J Clin Pharmacol; 2007 Feb; 47(2):192-200. PubMed ID: 17244770 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, safety and tolerability of single and multiple oral doses of aliskiren in healthy Chinese subjects: a randomized, single-blind, parallel-group, placebo-controlled study. Hu P; Bartlett M; Karan RS; Jiang J; Zhang S; Zhang J; Howard D; Yeh CM; Al-Fayoumi S; Jarugula V; Dole WP Clin Drug Investig; 2010; 30(4):221-8. PubMed ID: 20192280 [TBL] [Abstract][Full Text] [Related]
17. Species difference in the effect of grapefruit juice on intestinal absorption of talinolol between human and rat. Shirasaka Y; Kuraoka E; Spahn-Langguth H; Nakanishi T; Langguth P; Tamai I J Pharmacol Exp Ther; 2010 Jan; 332(1):181-9. PubMed ID: 19779132 [TBL] [Abstract][Full Text] [Related]
18. A study of dose-proportionality in the pharmacokinetics of the oral direct renin inhibitor aliskiren in healthy subjects. Limoges D; Dieterich HA; Yeh CM; Vaidyanathan S; Howard D; Dole WP Int J Clin Pharmacol Ther; 2008 May; 46(5):252-8. PubMed ID: 18538111 [TBL] [Abstract][Full Text] [Related]
19. A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects. Vaidyanathan S; Maboudian M; Warren V; Yeh CM; Dieterich HA; Howard D; Dole WP Curr Med Res Opin; 2008 Aug; 24(8):2313-26. PubMed ID: 18786303 [TBL] [Abstract][Full Text] [Related]
20. Prioritizing pharmacokinetic drug interaction precipitants in natural products: application to OATP inhibitors in grapefruit juice. Johnson EJ; Won CS; Köck K; Paine MF Biopharm Drug Dispos; 2017 Apr; 38(3):251-259. PubMed ID: 28032362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]